or Try an Advanced Search...

    Technical Analysis for ANTX - AN2 Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.32 1.98% 0.05
    ANTX closed down 1.73 percent on Wednesday, May 15, 2024, on 84 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ANTX trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 1.98%
    Down 3 Days in a Row Weakness 1.98%
    Down 4 Days in a Row Weakness 1.98%
    Lower Bollinger Band Touch Weakness 1.98%
    20 DMA Resistance Bearish 0.22%
    Gapped Up Strength 0.22%
    Down 3 Days in a Row Weakness 0.22%
    20 DMA Resistance Bearish -1.49%
    BB Squeeze Ended Range Expansion -1.49%
    Fell Below 20 DMA Bearish -4.34%
    Older End-of-Day Signals for ANTX ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 2 hours ago
    Up 1% about 2 hours ago
    Fell Below Previous Day's Low 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ANTX Chart by TradingView
    Basic chart:

    Profile

    AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Infectious Diseases Microbiology Tuberculosis Bacteriology Nontuberculous Mycobacteria Serious Infectious Diseases

    Is ANTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 29 AN2 Therapeutics GAAP EPS of -$0.57 beats by $0.17
    Mar 28 AN2 Therapeutics reports FY results
    Mar 28 AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights
    Feb 17 Spotlight On Nvidia, Walmart, Palo Alto Networks And CAGNY Conference
    Feb 12 Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Jan 30 AN2 Therapeutics to Present at Oppenheimer Healthcare Life Sciences Conference
    See more ANTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.15
    52 Week Low 2.2
    Average Volume 287,430
    200-Day Moving Average 11.78
    50-Day Moving Average 2.79
    20-Day Moving Average 2.41
    10-Day Moving Average 2.45
    Average True Range 0.17
    RSI (14) 30.56
    ADX 36.68
    +DI 13.47
    -DI 32.58
    Chandelier Exit (Long, 3 ATRs) 2.17
    Chandelier Exit (Short, 3 ATRs) 2.70
    Upper Bollinger Bands 2.59
    Lower Bollinger Band 2.23
    Percent B (%b) 0.11
    BandWidth 15.04
    MACD Line -0.23
    MACD Signal Line -0.28
    MACD Histogram 0.0557
    Fundamentals Value
    Market Cap 67.51 Million
    Num Shares 29.7 Million
    EPS -2.80
    Price-to-Earnings (P/E) Ratio -0.81
    Price-to-Sales 0.00
    Price-to-Book 4.28
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.57
    Resistance 3 (R3) 2.58 2.50 2.52
    Resistance 2 (R2) 2.50 2.42 2.49 2.50
    Resistance 1 (R1) 2.38 2.37 2.34 2.37 2.49
    Pivot Point 2.30 2.30 2.28 2.29 2.30
    Support 1 (S1) 2.18 2.22 2.14 2.17 2.05
    Support 2 (S2) 2.10 2.17 2.09 2.04
    Support 3 (S3) 1.98 2.10 2.02
    Support 4 (S4) 1.97